Financial Statements

Bayer Group Consolidated Statements
of Financial Position

	March 31, 2008	March 31, 2009	Dec. 31, 2008
	€ million	€ million	€ million
Noncurrent assets
Goodwill	8,190	8,649	8,647
Other intangible assets	14,221	13,520	13,951
Property, plant and equipment	8,561	9,596	9,492
Investments in associates	457	456	450
Other financial assets	995	1,374	1,197
Other receivables	996	425	458
Deferred taxes	611	1,212	1,156
	34,031	35,232	35,351
Current assets
Inventories	6,218	6,630	6,681
Trade accounts receivable	6,689	6,719	5,953
Other financial assets	570	423	634
Other receivables	1,494	1,110	1,284
Claims for income tax refunds	195	310	506
Cash and cash equivalents	2,717	4,365	2,094
Assets held for sale and discontinued operations	82	302	8
	17,965	19,859	17,160

Total assets	51,996	55,091	52,511

Equity
Capital stock of Bayer AG	1,957	1,957	1,957
Capital reserves of Bayer AG	4,028	4,028	4,028
Other reserves	11,543	11,034	10,278
	17,528	17,019	16,263
Equity attributable to non-controlling interest	77	75	77
	17,605	17,094	16,340

Noncurrent liabilities
Provisions for pensions and other post-employment benefits	4,970	6,094	6,347
Other provisions	1,273	1,250	1,351
Financial liabilities	12,686	12,736	10,614
Other liabilities	477	332	432
Deferred taxes	3,893	3,576	3,592
	23,299	23,988	22,336
Current liabilities
Other provisions	3,995	3,538	3,163
Financial liabilities	1,946	6,287	6,256
Trade accounts payable	2,220	1,986	2,377
Income tax liabilities	99	113	65
Other liabilities	2,703	2,085	1,961
Liabilities directly related to assets held for sale and discontinued operations	129	0	13
	11,092	14,009	13,835

Total equity and liabilities	51,996	55,091	52,511
2008 figures reclassified

Bayer Group Consolidated Statements of Financial Position

Bayer Group Consolidated Statements
of Financial Position